SCOTTSDALE, Ariz. – December 6, 2023 – Life365 Health a leader in virtual care, remote patient monitoring (RPM) and patient engagement announced today the acquisition of PillDrill, award-winning smart medication tracking system. With this acquisition, the Life365 Virtual Care Platform continues to differentiate itself in the digital health space, by providing integrated tools that move proactive and personalized care closer to individuals at home.Continue reading
Category Archives: AZBio News
AZBio CEO Shares Insights on the Impact of Arizona’s Bioindustry with Bob Roth on the Health Futures Podcast
In a recent episode of the radio show Health Futures, Taking Stock in You, hosted by Bob Roth, the guest was Joan Koerber-Walker, CEO and President of the Arizona Bioindustry Association (AZBio). The discussion revolved around Arizona’s transformation into a prominent hub for bioscience companies over the past two decades.Continue reading
Life365 Announces Strategic Acquisition of AffirmXH to Enhance Health Solutions
PHOENIX, Ariz. – December 5, 2023 – Life365, a leader in transforming healthcare through innovative solutions, announce today the acquisition of AffirmXH, a company renowned for its advanced biometric data analysis and no-code digital treatment platforms. The acquisition was completed under the LifeConnect division, and signifies a major step in expanding their reach in health monitoring.Continue reading
Industry Leader and Globally Recognized Patient Advocate John F. Crowley Appointed to Lead BIO as President & CEO
Biotech entrepreneur, company founder, tireless patient advocate, and U.S. Navy combat veteran will guide the life science industry in its mission to feed, fuel and heal the world
First Patient Enrolled in the PUERTA Phase 2A ARDS Clinical Trial: Treatment with Aqualung Therapeutics ALT-100 mAb
- A total of 14 PUERTA participating sites, 12 US and 2 Australian, in the Phase 2A trial of ALT-100 mAb in moderate to severe ARDS
- Aqualung awarded a $3M NIH R44 grant supporting the PUERTA Phase 2A Clinical Trial
BIO5 Institute Expands its Innovative Biosciences Research Model to Phoenix
The BIO5 Institute at the University of Arizona is set to embark on a groundbreaking journey by officially expanding its footprint to Phoenix. This move marks a significant step in fostering collaborative biosciences research across Arizona and beyond. Continue reading
AHCCCS Requests Federal Authority To Expand Eligibility for KidsCare
Nearly 10,000 More Children Could Become Eligible for CoverageContinue reading
Researchers, PIs, Technologists: Contact us with your wearable solutions for a chance to join WearTech Center’s next applied research cohort with matching funding up to $250,000.
Arizona’s WearTech Applied Research Center is developing its fourth cohort of applied research projects and is seeking novel wearable solutions to address challenges and opportunities within the existing healthcare and industrial sectors.Continue reading
ASU ranks in top 5 for inventions, patents, patent deals and startups
Arizona State University ranked among the top five research institutions without a medical school for the first time in fiscal year 2022 for inventions disclosed, U.S. patents secured, patent licenses and option deals closed, and startups launched, according to the Association of University Technology Managers’ latest survey of 180 reporting institutions on licensing activities at U.S. universities and research institutions.Continue reading